Patients with chemosensitive disease benefit most from high-dose chemotherapy, and those who receive such therapy early after achieving a partial response to first-line therapy have a high rate of cure. For patients considered to have chemosensitive disease at the time of transplantation, there is a significant difference in the actuarial progression-free survival rates for those who received high-dose therapy after attaining a partial response to first-line therapy (69% at 5 years) as compared with those with sensitive but relapsed disease (32% at 5 years) (P =. Patients with chemosensitive disease had an actuarial 5-year survival rate of 49% at 5 years compared with 13% for those with chemoresistant disease (P <. We serve a nationwide community of over 1.2 million artists and arts organizations offering a variety and programs and services that help artists strengthen the business side of their practice. When shes not writing, shes making ceramics at Centerpoint Ceramics. Before joining Fractured Atlas, she covered the book publishing industry for an audience of publishers at NetGalley. Fractured Atlas is a nonprofit technology company that works with artists. At Fractured Atlas, she shares tips and strategies for navigating the art world, interviews artists, and writes about creating a more equitable arts ecosystem. Fractures of the C1 vertebrae (atlas) are commonly the result of falls and other trauma, which cause hyperextension, or axial compression of the cervical spine. On multivariate analysis, the main prognostic factor was disease status at the time of ABMT. Revenue: 25 to 100 million (USD) Competitors: Unknown. The early procedure-related mortality rate was 7% (eight of 107 patients). The 5-year actuarial overall survival and progression-free survival rates were 41% and 35%, respectively. The minimum follow-up duration of all patients is 6 months.Īt 3 months, the overall response rate to BEAM and ABMT was 73% (41% complete response and 32% partial response). One hundred seven patients with relapsed or resistant intermediate-/high-grade NHL underwent high-dose carmustine, etoposide, cytarabine, and melphalan (BEAM) chemotherapy and ABMT at University College Hospitals between September 1981 and February 1993. It works with both individual artists and organizations, providing them with funding, business, and technological support in order to help them run their businesses more efficiently. To evaluate the outcome of patients with relapsed or resistant non-Hodgkin's lymphoma (NHL) undergoing high-dose chemotherapy and autologous bone marrow transplantation (ABMT) and to determine the main prognostic factors. Fractured Atlas Productions is a national organization that provides business and technological support to artists.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |